Alyeska Investment Group’s Autolus Therapeutics AUTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-214,300
| Closed | -$394K | – | 483 |
|
|
2023
Q1 | $394K | Sell |
214,300
-1,250,000
| -85% | -$2.3M | ﹤0.01% | 397 |
|
|
2022
Q4 | $2.78M | Buy |
+1,464,300
| New | +$2.78M | 0.03% | 299 |
|
|
2021
Q3 | – | Sell |
-208,706
| Closed | -$1.39M | – | 682 |
|
|
2021
Q2 | $1.39M | Hold |
208,706
| – | – | 0.02% | 562 |
|
|
2021
Q1 | $1.2M | Buy |
208,706
+42,897
| +26% | +$246K | 0.02% | 531 |
|
|
2020
Q4 | $1.48M | Sell |
165,809
-1,327
| -0.8% | -$11.9K | 0.02% | 388 |
|
|
2020
Q3 | $1.95M | Sell |
167,136
-101,900
| -38% | -$1.19M | 0.03% | 355 |
|
|
2020
Q2 | $4.31M | Sell |
269,036
-37,821
| -12% | -$606K | 0.07% | 276 |
|
|
2020
Q1 | $1.84M | Buy |
306,857
+99,546
| +48% | +$596K | 0.04% | 253 |
|
|
2019
Q4 | $2.74M | Buy |
207,311
+33,344
| +19% | +$440K | 0.04% | 261 |
|
|
2019
Q3 | $2.16M | Buy |
173,967
+75,000
| +76% | +$932K | 0.03% | 265 |
|
|
2019
Q2 | $1.59M | Buy |
+98,967
| New | +$1.59M | 0.02% | 312 |
|
|
2018
Q4 | – | Sell |
-46,500
| Closed | -$1.43M | – | 320 |
|
|
2018
Q3 | $1.43M | Sell |
46,500
-78,500
| -63% | -$2.41M | 0.02% | 302 |
|
|
2018
Q2 | $3.35M | Buy |
+125,000
| New | +$3.35M | 0.03% | 289 |
|